Back to Top Skip to main content

World AIDS Day puts spotlight on landmark DoD study

Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration.  (U.S. Army photo) Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration. (U.S. Army photo)

Recommended Content:

Immunization Healthcare | Research and Innovation | Global Health Engagement

The Walter Reed Army Institute of Research (WRAIR) hosted a World AIDS Day event Tuesday, Nov. 26, highlighting advances in DoD-led HIV research and celebrating the 10th anniversary of the Army-led RV144 HIV vaccine study.

WRAIR’s Military HIV Research Program or MHRP headed the RV144 study, the first-ever – and only to-date – clinical trial to demonstrate that an HIV vaccine regimen was safe and modestly effective in preventing HIV infection. The study sought to determine what methods could be used to lower risk of contracting the disease.

The RV144 trial represented a massive undertaking for the Army and serves as a model of international and interagency collaboration. It involved more than 16,000 adult volunteers and a large network of partners who still work with WRAIR today, including the Thai Ministry of Public Health; the National Institute of Allergy and Infectious Diseases – part of the National Institutes of Health; and Sanofi Pasteur.

In 2009, the Army announced that the study’s investigational prime-boost vaccine regimen lowered the rate of HIV infection by 31.2 percent. These results, although modest, gave the global community hope that a vaccine to prevent HIV infection is possible at a time when such an achievement seemed elusive.

“RV144 was the light at the time in the field, without which we may have given up,” said Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center and the featured speaker at WRAIR’s World AIDS Day event. “In the last 10 years of HIV vaccine progress, RV144 is the anchor.”

The landmark trial continues to provide scientific direction to help guide vaccine development and testing. RV144 and its follow-on trials allowed researchers to discover of risk factors, provide targets for optimizing vaccine boosting, and form a foundation for three HIV vaccine candidates currently undergoing efficacy testing. A video featuring many prominent HIV researchers who were involved with RV144 was shown at the World AIDS Day event.

Also at the event, Lt. Gen (Ret.) Eric B. Schoomaker, 42nd surgeon general of the United States Army and former commanding general of the United States Army Medical Command, highlighted the military’s earliest contributions to HIV research, which include the development of a disease staging system and promoting the finding that HIV can be transmitted heterosexually. The military’s HIV research efforts were consolidated in 1986 with the establishment of MHRP.

MHRP’s initial mission was to advance an HIV vaccine to protect service members and the global community from HIV, but has since expanded beyond vaccine development to include cure research and prevention and treatment services in Africa under the President’s Emergency Plan for AIDS Relief or PEPFAR. Via PEPFAR initiatives, WRAIR provides life-saving antiretroviral therapy to more than 350,000 people living with HIV in sub-Saharan Africa, which contributes to global health security.

WRAIR supports PEPFAR activities within military and civilian communities in four countries where it conducts research (Nigeria, Tanzania, Uganda, and Kenya), which strengthens community trust and provides an ethical framework for clinical studies. The Department of Defense HIV/AIDS Prevention Program, led by the U.S. Navy, is responsible for assisting foreign military partners with the development and implementation of military-specific HIV/AIDS prevention and treatment programs in more than 55 countries around the globe, also supported by PEPFAR.

“Those countries that partner with us on PEPFAR have a 40-percent decrease in violence and a 40-increase in political stability,” said WRAIR Commander Army Col. Deydre Teyhen. “So we say that soldier health is world health. But in fighting HIV/AIDS, WRAIR researchers are also working to advance world peace.”

More information can be found on the RV144 HIV Trial web page.

You also may be interested in...

Improving Defense Health Program Medical Research Processes

Report
8/8/2017

A report from the Defense Health Board (DHB) that summarizes the findings and recommendations from its independent review of Improving Defense Health Program (DHP) Medical Research Processes.

Recommended Content:

Research and Innovation | Health Readiness

Continuing Education for Department of Defense Health Professionals

Report
11/24/2015

Continuing Education for Department of Defense Health Professionals Report

Recommended Content:

Research and Innovation

Ethical Guidelines and Practices for US Military Medical Professionals

Report
3/3/2015

Defense Health Board (DHB) report summarizing the findings and recommendations from the DHB's independent review on Ethical Guidelines and Practices for U.S. Military Medical Professionals

Recommended Content:

Research and Innovation | Quality and Safety of Health Care (for Healthcare Professionals)

Form Follows Function Pursuing a World Class System for Health

Report
2/1/2015

Form Follows Function: Pursuing a World-Class System for Health

Recommended Content:

Research and Innovation | Access, Cost, Quality, and Safety

Dover Port Mortuary Independent Review Subcommittee Report Errata Sheet

Report
2/27/2012

Defense Health Board: Dover Port Mortuary Independent Review Subcommittee Report Errata Sheet

Recommended Content:

Quality and Safety of Health Care (for Healthcare Professionals) | Research and Innovation

Dover Port Mortuary Independent Review Subcommittee Final Report

Report
2/27/2012

Defense Health Board: Dover Port Mortuary Independent Review Subcommittee Final Report

Recommended Content:

Quality and Safety of Health Care (for Healthcare Professionals) | Research and Innovation

Battlefield Trauma Care Research Development Test and Evaluation Priorities

Report
6/14/2011

Defense Health Board: Battlefield Trauma Care Research Development Test and Evaluation Priorities

Recommended Content:

Research and Innovation

Routine Smallpox and Anthrax Immunizations Policies

Report
12/15/2010

Defense Health Board: Routine Smallpox and Anthrax Immunizations Policies

Recommended Content:

Immunization Healthcare | Immunizations | Deployment Health

Inclusion of the Measles Mumps and Rubella Vaccine

Report
12/11/2010

Defense Health Board: Inclusion of the Measles Mumps and Rubella Vaccine

Recommended Content:

Immunizations | Immunization Healthcare

Review of the Department of Defense Center for Deployment Health Research

Report
8/18/2010

Defense Health Board: Review of the Department of Defense Center for Deployment Health Research

Recommended Content:

Deployment Health | Research and Innovation

Defense Health Board Recommendations Pertaining to Pandemic Influenza Preparedness and Response

Report
9/11/2009

Defense Health Board: Defense Health Board Recommendations Pertaining to Pandemic Influenza Preparedness and Response

Recommended Content:

Immunization Healthcare

Transfer Storage and Oversight of the Warren AFB Cohort Serum Repository and Data Assets

Report
7/8/2009

Defense Health Board: Transfer Storage and Oversight of the Warren AFB Cohort Serum Repository and Data Assets

Recommended Content:

Immunizations | Immunization Healthcare

Vaccine Safety and Effectiveness Recommendation Memo

Report
6/4/2009

Defense Health Board: Vaccine Safety and Effectiveness Recommendation Memo

Recommended Content:

Immunizations | Immunization Healthcare | Research and Innovation

Design Plans for Walter Reed and Fort Belvoir

Report
5/1/2009

Defense Health Board: Design Plans for Walter Reed and Fort Belvoir

Recommended Content:

Access to Health Care | Research and Innovation

DHB Task Force Review of DoD Biodefense Infrastructure and Biological Research Portfolio

Report
4/29/2009

Defense Health Board: DHB Task Force Review of DoD Biodefense Infrastructure and Biological Research Portfolio

Recommended Content:

Research and Innovation
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.